New Zealand markets closed

Anhui Huaheng Biotechnology Co., Ltd. (688639.SS)

Shanghai - Shanghai Delayed price. Currency in CNY
Add to watchlist
120.98-2.75 (-2.22%)
At close: 03:00PM CST
Currency in CNY

Valuation measures4

Market cap (intra-day) 19.06B
Enterprise value 20.28B
Trailing P/E 42.15
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)9.40
Price/book (mrq)10.01
Enterprise value/revenue 13.19
Enterprise value/EBITDA 53.73

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 310.68%
S&P500 52-week change 326.27%
52-week high 3130.50
52-week low 382.21
50-day moving average 3112.89
200-day moving average 3105.85

Share statistics

Avg vol (3-month) 31.03M
Avg vol (10-day) 31.49M
Shares outstanding 5157.54M
Implied shares outstanding 6162.49M
Float 897.34M
% held by insiders 141.34%
% held by institutions 123.10%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 40.9
Forward annual dividend yield 40.74%
Trailing annual dividend rate 30.90
Trailing annual dividend yield 30.73%
5-year average dividend yield 4N/A
Payout ratio 431.36%
Dividend date 3N/A
Ex-dividend date 431 May 2023
Last split factor 21.45:1
Last split date 331 May 2023

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 22.29%
Operating margin (ttm)19.90%

Management effectiveness

Return on assets (ttm)9.40%
Return on equity (ttm)26.01%

Income statement

Revenue (ttm)2.04B
Revenue per share (ttm)12.87
Quarterly revenue growth (yoy)25.10%
Gross profit (ttm)N/A
EBITDA 603.53M
Net income avi to common (ttm)454.44M
Diluted EPS (ttm)2.87
Quarterly earnings growth (yoy)6.60%

Balance sheet

Total cash (mrq)370.92M
Total cash per share (mrq)2.36
Total debt (mrq)1.59B
Total debt/equity (mrq)83.55%
Current ratio (mrq)0.62
Book value per share (mrq)12.10

Cash flow statement

Operating cash flow (ttm)106.21M
Levered free cash flow (ttm)-706.63M